Expansion of pan-cancer mismatch repair testing: Implications for pembrolizumab eligibility and Lynch syndrome screening.

Cancer

Department of Colorectal Surgery, Ningbo No. 2 Hospital,, Ningbo, Zhejiang Province, China.

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.35624DOI Listing

Publication Analysis

Top Keywords

expansion pan-cancer
4
pan-cancer mismatch
4
mismatch repair
4
repair testing
4
testing implications
4
implications pembrolizumab
4
pembrolizumab eligibility
4
eligibility lynch
4
lynch syndrome
4
syndrome screening
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!